Abstract
Igf2 and H19 are closely linked, reciprocally imprinted genes on mouse distal chromosome 7. The paternally expressed Igf2 encodes a potent fetal growth factor and the maternally expressed H19 encodes a non-coding RNA (refs 1,2). Shared endoderm-specific enhancers 3′ to H19 are necessary for transcription of the maternal copy of H19 and the paternal copy of Igf2 (ref. 3), a chromatin boundary upstream of H19 preventing access of the enhancers to the maternal Igf2 promoters4,5,6,7,8. Mesoderm-specific control elements have not been identified, and the role of differentially methylated regions (DMRs) in Igf2 has not been addressed. Two DMRs in Igf2 are methylated on the active paternal allele, suggesting that they contain silencers9,10,11,12. Here we have deleted the DMR1 region in Igf2. Maternal transmission of the deletion results in biallelic expression of Igf2 in most mesodermally derived tissues without altering H19 imprinting or expression. Paternal or maternal transmission leads to continued postnatal transcription of Igf2, in contrast to the wild-type allele, which is silenced soon after birth. These results reveal a mesodermal silencer, which may be regulated by methylation and which has a major role in H19-independent expression and imprinting control of Igf2. Our results establish a new mechanistic principle for imprinted genes whereby epigenetically regulated silencers interact with enhancers to control expression, and suggest a new mechanism for loss of imprinting (LOI) of Igf2, which may be important in a number of diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bartolomei, M.S. & Tilghman, S.M. Genomic imprinting in mammals. Annu. Rev. Genet. 31, 493–525 (1997).
Constância, M., Pickard, B., Kelsey, G. & Reik, W. Imprinting mechanisms. Genome Res. 8, 881–900 (1998).
Leighton, P.A., Saam, J.R., Ingram, R.S., Stewart, C.L. & Tilghman, S.M. An enhancer deletion affects both H19 and Igf2 expression. Genes Dev. 9, 2079–2089 (1995).
Thorvaldsen, J.L., Duran, K.L. & Bartolomei, M.S. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev. 12, 3693–3702 (1998).
Bell, A.C. & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482–485 (2000).
Hark, A.T. et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405, 486–489 (2000).
Kanduri, C. et al. The 5′ flank of mouse H19 in an unusual chromatin conformation unidirectionally blocks enhancer-promoter communication. Curr. Biol. 10, 449–457 (2000).
Szabo, P., Tang, S.H., Rentsendorj, A., Pfeifer, G.P. & Mann, J.R. Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function. Curr. Biol. 10, 607–610 (2000).
Sasaki, H. et al. Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev. 6, 1843–1856 (1992).
Brandeis, M. et al. The ontogeny of allele-specific methylation associated with imprinted genes in the mouse. EMBO J. 12, 3669–3677 (1993).
Feil, R., Walter, J., Allen, N.D. & Reik, W. Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development 120, 2933–2943 (1994).
Moore, T. et al. Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. Proc. Natl Acad. Sci. USA 94, 12509–12514 (1997).
Feil, R., Handel, M.A., Allen, N.D. & Reik, W. Chromatin structure and imprinting: developmental control of DNase-I sensitivity in the mouse insulin-like growth factor II gene. Dev. Genet. 17, 240–252 (1995).
Neumann, B., Kubicka, P. & Barlow, D.P. Characteristics of imprinted genes. Nature Genet. 9, 12–13 (1995).
Ainscough, J.F.-X., John, R.M., Barton, S.C. & Surani, M.A. A skeletal muscle specific mouse Igf2 repressor lies 40 kb downstream of the gene. Development 127, 3923–3930 (2000).
Leighton, P.A., Ingram, R.S., Eggenschwiler, J., Efstratiadis, A. & Tilghman, S.M. Disruption of imprinting caused by deletion of the H19 region in mice. Nature 375, 34–39 (1995).
Hu, J.F., Vu, T.H. & Hoffman, A.R. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. J. Biol. Chem. 272, 20715–20720 (1997).
Ward, A. et al. Genomic regions regulating imprinting and insulin-like growth factor-II promoter 3 activity in transgenics: novel enhancer and silencer elements. Genes Funct. 1, 25–36 (1997).
Stöger, R. et al. Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell 73, 61–71 (1993).
Shemer, R., Birger, Y., Riggs, A.D. & Razin, A. Structure of the imprinted mouse Snrpn gene and establishment of its parental-specific methylation pattern. Proc. Natl Acad. Sci. USA 94, 10267–10272 (1997).
Drewell, R.A. et al. Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switch. Development 127, 3419–3428 (1997).
Ishihara, K. et al. Comparative genomic sequencing identifies novel tissue-specific enhancers and sequence elements for methylation-sensitive factors implicated in Igf2/H19 imprinting. Genome Res. 10, 664–671 (2000).
Moulton, T. et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet. 7, 440–447 (1994).
Steenman, M.J. et al. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet. 7, 433–439 (1994).
Reik, W. et al. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum. Mol. Genet. 4, 2379–2385 (1995).
Rainier, S., Dobry, C.J. & Feinberg, A.P. Loss of imprinting in hepatoblastoma. Cancer Res. 55, 1836–1838 (1995).
Brown, K.W. et al. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19 independent pathway. Hum. Mol. Genet. 5, 2027–2032 (1996).
Joyce, J.A. et al. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 6, 1543–1548 (1997).
Gu, H., Zou, Y.-R. & Rajewsky, K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP mediated gene targeting. Cell 73, 1155–1164 (1993).
Church, G.M. & Gilbert, W. Genomic sequencing. Proc. Natl Acad. Sci. USA 81, 1991–1995 (1984).
Dean, W. et al. Altered imprinted gene methylation and expression in completely ES-cell derived mouse fetuses: association with aberrant phenotypes. Development 125, 2273–2282 (1998).
Acknowledgements
We thank N. Allen and E. Grau for advice and help with ES cell culture; A. Surani, R. Drewell, J. Ainscough, H. Cedar, C. Rada, P. Fraser and R. Feil for discussion and comments on the manuscript; A. Ward and H. Cedar for communicating results before publication; and A. Smith for CGR ES cells. This work was supported by BBSRC, CRC, MRC. M.C. and S.L. were in receipt of FCT/PRAXIS XXI Scholarships (Portugal). G.K. is a senior fellow of the MRC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Constância, M., Dean, W., Lopes, S. et al. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Nat Genet 26, 203–206 (2000). https://doi.org/10.1038/79930
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/79930
